Sever, B., & Ciftci, H. (2026). Targeting ABL Tyrosine Kinase in Chronic Myeloid Leukemia: Design, Synthesis, Biological Evaluation, and Computational Studies of Novel Thiazolone Derivatives. Pharmaceutics, 18(6), 709. https://doi.org/10.3390/pharmaceutics18060709
Chicago Style (17th ed.) CitationSever, Belgin, and Halilibrahim Ciftci. "Targeting ABL Tyrosine Kinase in Chronic Myeloid Leukemia: Design, Synthesis, Biological Evaluation, and Computational Studies of Novel Thiazolone Derivatives." Pharmaceutics 18, no. 6 (2026): 709. https://doi.org/10.3390/pharmaceutics18060709.
MLA (9th ed.) CitationSever, Belgin, and Halilibrahim Ciftci. "Targeting ABL Tyrosine Kinase in Chronic Myeloid Leukemia: Design, Synthesis, Biological Evaluation, and Computational Studies of Novel Thiazolone Derivatives." Pharmaceutics, vol. 18, no. 6, 2026, p. 709, https://doi.org/10.3390/pharmaceutics18060709.